Curium Is Said to Near About $7 Billion Acquisition of Lantheus
Bloomberg 2026-07-27 21:22:16
Context: Curium is in advanced talks to acquire Lantheus Holdings Inc., a radiopharma company, in a deal that could be announced in the coming days. The acquisition is valued at approximately $7 billion. The talks are at an advanced stage, with an announcement potentially imminent.
Key Facts
- Curium is in advanced talks to acquire Lantheus Holdings Inc., a radiopharma company, with people familiar with the matter indicating that an announcement could be made in the coming days.
- The acquisition is valued at approximately $7 billion, representing a significant expansion of Curium's presence in the radiopharma industry.
- Lantheus Holdings Inc. is the target of the proposed acquisition, with the deal expected to be announced soon, subject to any final negotiations or regulatory approvals.